Search clinical trials for: Hepatocellular carcinoma (HCC)

Total 30055 results

Sohag University

Completed

ALBI and PALBI Scores and HCC Prognosis

Hepatocellular Carcinoma (HCC) Prognosis

Egypt
International Agency for Research on Cancer
Universidad de Murcia; Federico II University; University of Tromso; Imperial College... and other collaborators

Completed

Metabolic Signature of Healthy Lifestyle and HCC

Hepatocellular Carcinoma
British Columbia Cancer Agency
University of British Columbia

Unknown

Dynamic Contrast Enhanced HCC SABR Liver Study

Carcinoma, Hepatocellular

Canada
Leiden University Medical Center
Mirada Medical

Completed

Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation (IAMCOMPLETE)

HCC

Netherlands
The University of Hong Kong

Recruiting

TACE and SBRT Followed by Double Immunotherapy for Downstaging Hepatocellular Carcinoma

HCC

Hong Kong
Institut für Klinische Krebsforschung IKF GmbH...
Hannover Medical School; AstraZeneca

Recruiting

Durvalumab and Tremelimumab in Combination With Either Y-90 SIRT or DEB-TACE for Intermediate Stage HCC

HCC | Hepatocellular Carcinoma Non-resectable

Germany
Zhongshan Hospital (Xiamen), Fudan University

Recruiting

Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer

Hepatocellular Carcinoma | Chronic Hepatitis B

China
Kyowa Kirin Co., Ltd.

Completed

A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC) (JET-HCC)

Liver Cancer

Japan
Mansoura University

Unknown

Role of Serum Regucalcin in Diagnosis of Hepatocellular Carcinoma

Role of Serum Regucalcin in Diagnosis of HCC

Egypt
Tianjin Medical University Cancer Institute and...

Recruiting

Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment Failure

HCC

China
Sidney Kimmel Cancer Center at Thomas Jefferson...
Pfizer

Active, not recruiting

A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer

HCC | Advanced Hepatocellular Carcinoma | Liver Cancer

United States
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Lenvatinib, Sintilimab Plus SIRT for Unresectable HCC

Hepatocellular Carcinoma

China
Sun Yat-sen University

Recruiting

Neo-TACE-HAIC for PVTT-HCC (NeoconceptC)

Hepatocellular Carcinoma | Portal Vein Thrombosis

China
Sun Yat-sen University

Recruiting

RFA Versus SBRT for Recurrent Small HCC

Hepatocellular Carcinoma

China
Sun Yat-sen University
Second Military Medical University

Not yet recruiting

Laparoscopic Surgery VS RFA for Recurrent HCC

Hepatocellular Carcinoma
National Cancer Centre, Singapore
Perspectum

Completed

LiverMultiScan Analysis of MRI Scans in HCC

Hepatocellular Carcinoma

Singapore
Xiangya Hospital of Central South University

Active, not recruiting

Thermal Ablation Followed by Immunotherapy for HCC

Hepatocellular Carcinoma Non-resectable

China
Benha University
Beni-Suef University

Completed

RFA for Treatment of Intermediate Stage HCC

Hepatocellular Carcinoma

Egypt
Chinese University of Hong Kong

Completed

Hepatocellular Carcinoma (HCC) Transarterial Chemoembolisation (TACE) +Axitinib

Hepatocellular Carcinoma

Hong Kong
Institut de Cancérologie de Lorraine

Completed

HCC Response Assessment by MRI After SBRT

Carcinoma, Hepatocellular
Philipps University Marburg Medical Center

Withdrawn

Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

Germany
National Taiwan University Hospital

Unknown

PLA for HCC and Esophageal ca Serum

Hepatocellular Carcinoma | Esophageal Cancer

Taiwan
Pfizer

Completed

Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes

Diabetes Mellitus, Type 1

United States, Canada
Kaoshiung Chang Gung Memorial Hospital

Recruiting

Lenvatinib Therapy in HCC Patients After LDLT

Liver Transplantation | Hepatocellular Carcinoma

Taiwan
OHSU Knight Cancer Institute
Oregon Health and Science University; American Society of Clinical Oncology; Radiological... and other collaborators

Withdrawn

Y-90 Versus SBRT for Inoperable HCC

Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IIIA Hepatocellular Carcinoma AJCC v8 | Stage IVA Hepatocellular Carcinoma AJCC v8 | Stage IIIB Hepatocellular Carcinoma AJCC v8 | Stage IB Hepatocellular Carcinoma AJCC v8 | Stage II Hepatocellular Carcinoma AJCC v8 | Stage... and other conditions

United States
Ashwin Somasundaram
Merck Sharp & Dohme LLC; Hoosier Cancer Research Network

Active, not recruiting

Pembrolizumab Plus Y90 Radioembolization in HCC Subjects

Hepatocellular Carcinoma

United States
Epigenomics, Inc
Innovis LLC

Completed

HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma | Cirrhosis, Liver | Liver Cancer | Hepatic Cirrhosis

United States
Biogen

Completed

Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

United States, Singapore, Taiwan, United Kingdom
Sun Yat-sen University

Not yet recruiting

Sintilimab Plus Bevacizumab as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Curative Resection (DaDaLi)

HCC | Immunotherapy | Adjuvant Therapy

China
Immunitor LLC
Immunitor Inc.

Unknown

Open Label Trial of Immunotherapy for Advanced Liver Cancer (HCC)

Liver Cirrhosis | HCC

Mongolia
AstraZeneca

Recruiting

A Phase I/II Study to Evaluate AZD5851 in GPC3+ Advanced/Recurrent Hepatocellular Carcinoma (ATHENA)

Hepatocellular Carcinoma

United States, Korea, Republic of
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma (IMMUNO-TH)

Liver Transplant | Hepatocellular Carcinoma Recurrent | Systemic Treatment
University of Missouri-Columbia
Penn State University

Completed

Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor

Hepatocellular Cancer

United States
The First Affiliated Hospital with Nanjing Medical...

Unknown

Anlotinib Hydrochloride Combined With Sintilimab Injection in the Treatment of Advanced Hepatocellular Carcinoma (HCC)

Advanced Hepatocellular Carcinoma

China
University Hospital, Montpellier

Completed

Small and Steatotic Hepatocellular Carcinoma

HCC

France
Indiana University
BTG International Inc.

Terminated

A Study to Assess the Effect of Y-90 Therapy on Non-target/Background Liver

HCC | Liver Cancer

United States
Li Chen

Unknown

Comparison of Liver and Renal Function After Transarterial Chemoembolization for Primary Hepatocellular Carcinoma With Iso-osmolar Contrast Media and Low Osmolar Contrast Media

Primary Hepatocellular Carcinoma

China
University Health Network, Toronto
Princess Margaret Hospital, Canada

Completed

Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4)

Hepatocellular Carcinoma | Hepatic Metastasis

Canada
Terumo Europe N.V.

Recruiting

Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma. (HOMIE-166)

Hepatocellular Carcinoma

Germany
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated With Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National Cohort (OPERANDI-HCC)

Hepatocellular Carcinoma | Radioembolization

France
Daiichi Sankyo, Inc.
ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...

Completed

Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy (METIV-HCC)

Hepatocellular Carcinoma

United States, France, Italy, Germany, Spain, Switzerland, Belgium, Portugal, Netherlands, Australia, Brazil, Canada, Austria, New Zealand, Sweden, Argentina
Jiping Wang, MD, PhD
AstraZeneca; Sirtex Medical

Recruiting

SIRT With Tremelimumab and Durvalumab for Resectable HCC

Hepatocellular Carcinoma | Hepatocellular Cancer | Resectable Hepatocellular Carcinoma

United States
Second Affiliated Hospital, School of Medicine,...

Recruiting

RFA Plus Carrizumab vs Carrizumab Alone for HCC

Immunosuppression | Radiofrequency Ablation | Tumor Immunity

China
National Cancer Centre, Singapore
Merck Sharp & Dohme LLC; National Medical Research Council (NMRC), Singapore

Active, not recruiting

Longitudinal Immune-phenotyping of HCC Following MK-3475

Hepatocellular Carcinoma

Singapore
Teclison Ltd.

Suspended

TATE Versus TACE in Intermediate Stage HCC (TATE)

Carcinoma, Hepatocellular

United States
Chang Gung Memorial Hospital

Completed

Hypermethylation of VTRNA2-1 Promoter in HCC Outcome

Hepatocellular Carcinoma Resectable

Taiwan
Gangneung Asan Hospital
Soonchunhyang University Hospital

Unknown

Comparison of SBRTand Repeat TACE for HCC (STH)

HepatoCellular Carcinoma

Korea, Republic of
Sun Yat-sen University

Completed

CIK Treatment for HCC Patient Underwent Radical Resection

Carcinoma, Hepatocellular

China
Eastern Hepatobiliary Surgery Hospital

Completed

Targeted Internal Radiation Therapy in Advanced HCC Patients.

Advanced Hepatocellular Carcinoma | Internal Radiation

China
National Taiwan University Hospital

Unknown

3T MRI to Predict TACE Response of HCC

Carcinoma, Hepatocellular

Taiwan

Search clinical trials for: Hepatocellular carcinoma (HCC)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations